HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.

AuthorsH de Lavallade, C Faucher, S Fürst, J El-Cheikh, N Vey, D Coso, R Bouabdallah, A-M Stoppa, J-A Gastaut, D Blaise, M Mohty
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 37 Issue 7 Pg. 709-10 (Apr 2006) ISSN: 0268-3369 [Print] England
PMID16474410 (Publication Type: Case Reports, Letter)
Chemical References
  • HLA Antigens
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cyclophosphamide (therapeutic use)
  • Doxorubicin (therapeutic use)
  • Follow-Up Studies
  • Graft vs Host Disease (diagnosis, therapy)
  • Graft vs Tumor Effect
  • HLA Antigens (analysis)
  • Humans
  • Leukemia, Prolymphocytic (diagnosis, therapy)
  • Leukemia, T-Cell (diagnosis, therapy)
  • Male
  • Prednisone (therapeutic use)
  • Remission Induction
  • Siblings
  • Stem Cell Transplantation (adverse effects)
  • Time Factors
  • Tissue Donors
  • Transplantation Conditioning (methods)
  • Transplantation, Homologous
  • Treatment Outcome
  • Vincristine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: